Xianfeng Wang
- Infectious Diseases top 10%
- Molecular Biology
- Epidemiology
- Physiology
- Geriatrics and Gerontology top 5%
- Co-authors
- Yanrong WangLei LiuYingxia LiuHang ShiLing LiBingzhong XueBarbara K. YozaVidula Vachharajani
- Topics
- Sirtuins and Resveratrol in Medicine (5 papers)COVID-19 Clinical Research Studies (5 papers)SARS-CoV-2 and COVID-19 Research (4 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Xianfeng Wang
25 papers receiving 864 citations
Peers
Comparison fields: 5 of 101
- Infectious Diseases 237
- Molecular Biology 216
- Epidemiology 180
- Physiology 137
- Geriatrics and Gerontology 120
Countries citing papers authored by Xianfeng Wang
This map shows the geographic impact of Xianfeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianfeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianfeng Wang more than expected).
Fields of papers citing papers by Xianfeng Wang
This network shows the impact of papers produced by Xianfeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianfeng Wang. The network helps show where Xianfeng Wang may publish in the future.
Co-authorship network of co-authors of Xianfeng Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Xianfeng Wang. A scholar is included among the top collaborators of Xianfeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianfeng Wang. Xianfeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 6 | |
| 6 | 236 | |
| 7 | 2 | |
| 8 | 10 | |
| 9 | 31 | |
| 10 | 42 | |
| 11 | 26 | |
| 12 | 15 | |
| 13 | 44 | |
| 14 | 49 | |
| 15 | 15 | |
| 16 | 19 | |
| 17 | 31 | |
| 18 | 52 | |
| 19 | 110 | |
| 20 | 4 |
About Xianfeng Wang
Xianfeng Wang is a scholar working on Geriatrics and Gerontology, Critical Care and Intensive Care Medicine and Infectious Diseases, having authored 27 papers that have together received 881 indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (5 papers), COVID-19 Clinical Research Studies (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). The work is most often cited by research in Geriatrics and Gerontology (120 citations), Infectious Diseases (237 citations) and Physiology (37 citations). Xianfeng Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yanrong Wang, Lei Liu, Yingxia Liu, Hang Shi, Ling Li, Bingzhong Xue, Barbara K. Yoza, Vidula Vachharajani, Nancy Buechler and Zhenggang Yang. Their work appears in journals such as PLoS ONE, Diabetes and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.